These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 2812653

  • 1. Yolk sac failure in embryopathy due to hyperglycemia: horseradish peroxidase uptake in the assessment of yolk sac function.
    Reece EA, Pinter E, Leranth C, Hobbins JC, Mahoney MJ, Naftolin F.
    Obstet Gynecol; 1989 Nov; 74(5):755-62. PubMed ID: 2812653
    [Abstract] [Full Text] [Related]

  • 2. Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions.
    Pinter E, Reece EA, Leranth CZ, Sanyal MK, Hobbins JC, Mahoney MJ, Naftolin F.
    Teratology; 1986 Feb; 33(1):73-84. PubMed ID: 3738811
    [Abstract] [Full Text] [Related]

  • 3. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
    Khandelwal M, Reece EA, Wu YK, Borenstein M.
    Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
    [Abstract] [Full Text] [Related]

  • 4. Fluorometric analysis of endocytosis and lysosomal proteolysis in the rat visceral yolk sac during whole embryo culture.
    Ambroso JL, Larsen SV, Brabec RK, Harris C.
    Teratology; 1997 Sep; 56(3):201-9. PubMed ID: 9358607
    [Abstract] [Full Text] [Related]

  • 5. The yolk sac theory: closing the circle on why diabetes-associated malformations occur.
    Reece EA, Pinter E, Homko C, Wu YK, Naftolin F.
    J Soc Gynecol Investig; 1994 Sep; 1(1):3-13. PubMed ID: 9419739
    [Abstract] [Full Text] [Related]

  • 6. Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro.
    Yang P, Zhao Z, Reece EA.
    Am J Obstet Gynecol; 2008 Mar; 198(3):321.e1-7. PubMed ID: 18177823
    [Abstract] [Full Text] [Related]

  • 7. Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor.
    Hunter ES, Phillips LS, Goldstein S, Sadler TW.
    Teratology; 1991 Apr; 43(4):331-40. PubMed ID: 2048042
    [Abstract] [Full Text] [Related]

  • 8. Teratogenic antibody internalization by rat visceral yolk-sac endoderm in vitro: an ultrastructural colloidal gold tracer study.
    Leung CC, Yan CL, Cheewatrakoolpong B.
    Am J Anat; 1988 Oct; 183(2):125-9. PubMed ID: 3202080
    [Abstract] [Full Text] [Related]

  • 9. Transport across endodermal cells of the chick yolk sac during early stages of development.
    Mobbs IG, McMillan DB.
    Am J Anat; 1981 Mar; 160(3):285-308. PubMed ID: 7223677
    [Abstract] [Full Text] [Related]

  • 10. The role of the visceral yolk sac in hyperglycemia-induced embryopathies in mouse embryos in vitro.
    Hunter ES, Sadler TW.
    Teratology; 1992 Feb; 45(2):195-203. PubMed ID: 1615429
    [Abstract] [Full Text] [Related]

  • 11. In vitro studies on the effect of yolk sac antisera on functions of the visceral yolk sac: I. Pinocytosis and transport of small molecules.
    Lerman S, Koszalka TR, Jensen M, Andrew CL, Beckman DA, Brent RL.
    Teratology; 1986 Dec; 34(3):335-41. PubMed ID: 3798369
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of proteolysis in rat yolk sac as a cause of teratogenesis. Effects of leupeptin in vitro and in vivo.
    Freeman SJ, Lloyd JB.
    J Embryol Exp Morphol; 1983 Dec; 78():183-93. PubMed ID: 6663224
    [Abstract] [Full Text] [Related]

  • 13. Tumor promoter actions on rat embryonic development in culture.
    Huber BE, Brown NA.
    Cancer Res; 1983 Nov; 43(11):5544-51. PubMed ID: 6616482
    [Abstract] [Full Text] [Related]

  • 14. Studies on the mechanism of trypan blue teratogenicity in the rat developing in vivo and in vitro.
    Rogers JM, Daston GP, Ebron MT, Carver B, Stefanadis JG, Grabowski CT.
    Teratology; 1985 Jun; 31(3):389-99. PubMed ID: 4012648
    [Abstract] [Full Text] [Related]

  • 15. Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy.
    Pinter E, Reece EA, Leranth CZ, Garcia-Segura M, Hobbins JC, Mahoney MJ, Naftolin F.
    Am J Obstet Gynecol; 1986 Oct; 155(4):691-702. PubMed ID: 3094372
    [Abstract] [Full Text] [Related]

  • 16. Evidence that protein ingested by the rat visceral yolk sac yields amino acids for synthesis of embryonic protein.
    Freeman SJ, Lloyd JB.
    J Embryol Exp Morphol; 1983 Feb; 73():307-15. PubMed ID: 6875463
    [Abstract] [Full Text] [Related]

  • 17. Albumin and transferrin synthesis in whole rat embryo cultures.
    Williams CL, Priscott PK, Oliver IT, Yeoh GC.
    J Embryol Exp Morphol; 1986 Mar; 92():33-41. PubMed ID: 3723066
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to the 280-kd coated pit protein, target of teratogenic antibodies, produce alterations in the traffic of internalized proteins.
    Le Panse S, Ayani E, Mulliez N, Chatelet F, Cywiner-Golenzer C, Galceran M, Citadelle D, Roux C, Ronco P, Verroust P.
    Am J Pathol; 1994 Dec; 145(6):1526-36. PubMed ID: 7992855
    [Abstract] [Full Text] [Related]

  • 19. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis.
    Reece EA, Ji I, Wu YK, Zhao Z.
    Am J Obstet Gynecol; 2006 Oct; 195(4):1075-80. PubMed ID: 17000240
    [Abstract] [Full Text] [Related]

  • 20. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period.
    Trocino RA, Akazawa S, Takino H, Takao Y, Matsumoto K, Maeda Y, Okuno S, Nagataki S.
    Endocrinology; 1994 Feb; 134(2):869-78. PubMed ID: 8299581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.